OBJECTIVES: The purpose of this study was to examine the effects of a structured, 8-week, Mindfulness-Based Stress Reduction (MBSR) program on perceived stress, mood, endocrine function, immunity, and functional health outcomes in individuals infected with the human immunodeficiency virus (HIV). DESIGN: This study used a quasiexperimental, nonrandomized design. METHODS: Subjects were specifically recruited (nonrandom) for intervention (MBSR) or comparison group. Data were collected at pretest and post-test in the MBSR group and at matched times in the comparison group. t Tests where performed to determine within-group changes and between-group differences. RESULTS: Natural killer cell activity and number increased significantly in the MBSR group compared to the comparison group. No significant changes or differences were found for psychological, endocrine, or functional health variables. CONCLUSIONS: These results provide tentative evidence that MBSR may assist in improving immunity in individuals infected with HIV.
OBJECTIVES: The purpose of this study was to examine the effects of a structured, 8-week, Mindfulness-Based Stress Reduction (MBSR) program on perceived stress, mood, endocrine function, immunity, and functional health outcomes in individuals infected with the human immunodeficiency virus (HIV). DESIGN: This study used a quasiexperimental, nonrandomized design. METHODS: Subjects were specifically recruited (nonrandom) for intervention (MBSR) or comparison group. Data were collected at pretest and post-test in the MBSR group and at matched times in the comparison group. t Tests where performed to determine within-group changes and between-group differences. RESULTS: Natural killer cell activity and number increased significantly in the MBSR group compared to the comparison group. No significant changes or differences were found for psychological, endocrine, or functional health variables. CONCLUSIONS: These results provide tentative evidence that MBSR may assist in improving immunity in individuals infected with HIV.
Authors: Carolyn Y Fang; Diane K Reibel; Margaret L Longacre; Steven Rosenzweig; Donald E Campbell; Steven D Douglas Journal: J Altern Complement Med Date: 2010-05 Impact factor: 2.579
Authors: Jill E Bormann; Allen L Gifford; Martha Shively; Tom L Smith; Laura Redwine; Ann Kelly; Sheryl Becker; Madeline Gershwin; Patricia Bone; Wendy Belding Journal: J Behav Med Date: 2006-07-18
Authors: Autumn M Gallegos; Michael Hoerger; Nancy L Talbot; Michael S Krasner; Jennifer M Knight; Jan A Moynihan; Paul R Duberstein Journal: J Altern Complement Med Date: 2013-02-05 Impact factor: 2.579
Authors: S Jedel; A Hoffman; P Merriman; B Swanson; R Voigt; K B Rajan; M Shaikh; H Li; A Keshavarzian Journal: Digestion Date: 2014-02-14 Impact factor: 3.216
Authors: Mary Catherine George; Arada Wongmek; Michelle Kaku; Alexandra Nmashie; Jessica Robinson-Papp Journal: Behav Med Date: 2015-12-11 Impact factor: 3.104
Authors: Jeanne K Kemppainen; John M Brion; Mark Leary; Dean Wantland; K Sullivan; Kathleen Nokes; Catherine A Bain; Puangtip Chaiphibalsarisdi; Wei-ti Chen; William L Holzemer; Lucille Sanzero Eller; Scholastika Iipinge; Mallory O Johnson; Carmen Portillo; Joachim Voss; Lynda Tyer-Viola; Inge B Corless; Patrice K Nicholas; Carol Dawson Rose; J Craig Phillips; Elizabeth Sefcik; Marta Rivero Mendez; Kenn M Kirksey Journal: AIDS Care Date: 2013-03-25